APA (7th ed.) Citation

Rasko, N. B., Nahm, C. B., Turchini, J., Teh, R., Rasmussen, H., Byeon, S., . . . Mittal, A. (2025, January). FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival. Cancer Medicine.

Chicago Style (17th ed.) Citation

Rasko, Nathalie B., et al. "FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival." Cancer Medicine Jan. 2025.

MLA (9th ed.) Citation

Rasko, Nathalie B., et al. "FXYD3 Is Frequently Expressed in Pancreatic Ductal Adenocarcinoma but Does Not Predict Survival." Cancer Medicine, Jan. 2025.